Monthly News Roundup - July 2017
New approvals for HCV, breast cancer, sickle cell disease, and psoriasis top the charts in July: Gilead’s Vosevi is given the green light for retreatment in six HCV genotypes, Nerlynx is cleared to extend reduction of breast cancer recurrence, and oral Endari is approved for sickle cell disease. Janssen’s first-in-class Tremfya is given the go-ahead for plaque psoriasis, and Amgen’s Blincyto, previously cleared for ALL on an accelerated basis, is now fully FDA-approved. Read more...
New Drug Approvals
The following drugs have recently been approved by the FDA.
Date of Approval: July 18, 2017
Treatment for: Chronic Hepatitis C
Date of Approval: July 17, 2017
Treatment for: Breast Cancer -- Adjuvant
Date of Approval: July 13, 2017
Treatment for: Plaque Psoriasis
Date of Approval: July 7, 2017
Treatment for: Sickle Cell Anemia
|• || |
| Learn About A Moderate to Severe Rheumatoid Arthritis Treatment. |
|• || |
| Get Educated About a Treatment Option for Lung Cancer |
|• || |
| Discover A Treatment Option For Major Depressive Disorder Today |
New Indications and Dosage Forms
Drugs that have gained FDA approval for the treatment of additional diseases/conditions or new dosage forms/regimens.
New Formulation Approved: July 20, 2017
Now Approved: Self-Injectable Subcutaneous Formulation
New Indication Approved: June 30, 2017
Now Approved for: Psoriatic Arthritis
Patient Population Altered: July 21, 2017
Now Approved for: Pediatric Patients 12 Years and Older with Advanced Melanoma
First-Time Generic Approvals
First Time Generics are those drug products that have never been approved before as generic drug products and are new generic products to the marketplace.
5 mg and 10 mg
Approved: July 12, 2017 - Mylan Pharmaceuticals Inc.
Generic for: Effient
Other Drug News
Just a Few Vaccine Refusers Could Endanger ManyJuly 24, 2017
With a small percentage of US parents not vaccinating their children for "non-medical" reasons, a new study warns that even a few such families can trigger a big jump in local measles cases.
Some Medicines Boost Sensitivity to SunJuly 17, 2017
It's well-known that too much time in the sun puts your skin at risk, and it's extra important to limit sun exposure when you're taking certain prescription medications, a pharmaceutical expert warns.
Can Your Heartburn Meds Shorten Your Life?July 3, 2017
Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests.
| || |
FDA MedWatch Alerts
FDA Drug Safety Labeling Changes
This is a summary of the FDA drug labeling changes for July 2016. Click on a drug name to view the changes in more detail.
Note: the drug safety labeling changes listed above may not be a complete list. Please visit the link below for the entire current list and historical archive.
Tools & Helpful Links
Use this feature to find information on diseases, symptoms, injuries, medical tests and surgical procedures.
The Pill Identifier enables a search for unidentified pills by imprint code or shape/color.
Drug Interactions Checker
Increasingly popular as more healthcare professionals and consumers make the effort to seek detailed information on drug-drug and drug-food interactions.
All the latest information on FDA Approvals and recent additions to the database.
News & Articles
Roundup of recent drug-related news and press releases. also latest news from FDA Medwatch service including timely publication of recalls, withdrawals, warnings, and label/packaging changes.
About This Newsletter
Drugs.com is not affiliated with any pharmaceutical company. We are dedicated to providing consumers and health professionals with objective information about prescription-medication discoveries and side effects.
This information is not intended to be medical advice. You should contact your physician before making any changes to your health care. Drugs.com is not responsible for content provided by third-party websites.
About Your Subscription
We always appreciate feedback so if you wish to give us your comments/ praise/ rebuke please Contact Us
Thanks so much for your continued support!
The Editorial TeamDrugs.com